Recursion accelerates drug discovery by combining hardware, software, and large biological data to build data-driven workflows. It runs thousands of wet-lab experiments weekly to profile genes and compounds across many cell types, feeding results into its high-power BioHive 1 computer to uncover billions of gene–compound relationships. This integration of vast datasets, high-throughput experiments, and specialized computing enables rapid generation of actionable drug candidates, set within a model that emphasizes strategic partnerships with pharma companies, research institutions, and healthcare providers. The goal is to decode biology at scale and translate discoveries into new medicines that improve patient lives through collaboration and commercialization.
Company Size
501-1,000
Company Stage
IPO
Headquarters
Salt Lake City, Utah
Founded
2013
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?